Sunesis Pharmaceuticals to Present at BIO CEO and Investor Conference
February 10 2006 - 8:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., Feb. 10 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Daniel N. Swisher, Jr., Chief Executive Officer and President, will
present a company update at the 8th Annual BIO CEO and Investor
Conference. The presentation will take place on Tuesday, February
14, 2006 at 11:30 a.m. at the Waldorf Astoria in New York City.
Interested parties may access a webcast of the presentation by
visiting the Sunesis website at http://ir.sunesis.com/ . A replay
of the webcast will be archived on the "Calendar of Events" page in
the Investors and Media section of the Sunesis website for two
weeks until February 28, 2006. About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on
the discovery, development and commercialization of novel small
molecule therapeutics for oncology and other serious diseases.
Sunesis has built a broad product candidate portfolio through
internal discovery and in-licensing of novel cancer therapeutics.
Sunesis is advancing its product candidates through in-house
research and development efforts and strategic collaborations with
leading pharmaceutical and biopharmaceutical companies. For further
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/ . Forward-Looking Statements This press
release may contain forward-looking statements that involve
substantial risks and uncertainties. Sunesis may not actually
achieve the plans, intentions or expectations contained in such
forward-looking statements. Actual results or events could differ
materially from the plans, intentions and expectations contained in
such forward-looking statements. Sunesis does not assume any
obligation to update any such forward-looking statements.
DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: investors, Eric
Bjerkholt, CFO of Sunesis Pharmaceuticals, Inc., +1-650-266-3717;
or media, Karen L. Bergman or Michelle Corral of BCC Partners,
+1-650-575-1509, or +1-415-794-8662 Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024